Crystal Pharma’s manufacturing facilities have been designed from the outset in accordance with FDA guidelines. The “clean room” for the physical treatment of the final products, has been specifically designed in accordance with approved pharmaceuticals standards. The facilities also include a modern well-equipped pilot plant which permits the development of efficient and reliable processes which take into account and respect the environment.

Crystal Pharma specialises in the development of new processes, which can be designed to ensure the non-infringement of patents, through the application of alternative synthetic procedures. The R&D support facilities, together with the possibilities for process scale-up and plant scale production, make Crystal Pharma the ideal partner for laboratories of Generics specialties. At the same time, Crystal Pharma is able to provide and characterise data and samples of related impurities, stability studies and so on, in order to elaborate extensive and complete “Drug Master Files” for its products.

Crystal Pharma has invested in quality, and now offers a plant for the manufacture of sterile steroids by crystallization. Our proposal is to offer products with the highest standard of quality. This state-of-the-art technology avoids endotoxins and microorganism in products to be used for parenteral, anti-asthmatic or oftalmicl use. This new plant is also equipped with a sterile microniser to maintain the highest quality for the final product handling.